Expert consensus on the management of patients with cerebrovascular diseases and lipid metabolism disorders: focus on primary and secondary prevention
- 30 January 2026
- journal article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (11)
Abstract
This consensus provides valuable advice on the clinical management of patients and the interpretation of research data in areas not covered by clinical guidelines. It is intended for neurologists, cardiologists, and general practitioners. It combines data from modern studies on the risk of cognitive impairment and stroke in patients with lipid metabolism disorders. Approaches and algorithms for hypertriglyceridemia correction as part of the primary and secondary prevention of diseases associated with cerebrovascular diseases and atherosclerosis were developed.Keywords
This publication has 56 references indexed in Scilit:
- Importance of Age and Sex in Carotid Artery Plaque Detection and Cardiovascular Disease RiskJAMA Cardiology, 2025
- Assessing the Efficacy of Omega-3 Fatty Acids + Statins vs. Statins Only on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of 40,991 PatientsCurrent Problems in Cardiology, 2023
- Intracranial arteriosclerosis and the risk of dementia: A population‐based cohort studyAlzheimer's & Dementia, 2023
- Fellow's voice: Hypertriglyceridemia: Understanding the current guidelineAmerican Journal of Preventive Cardiology, 2022
- Association of Ischemic Stroke Incidence, Severity, and Recurrence With Dementia in the Atherosclerosis Risk in Communities Cohort StudyJAMA Neurology, 2022
- Cerebral white matter hyperintensity is associated with intracranial atherosclerosis in a healthy populationAtherosclerosis, 2017
- Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular DiseaseJACC, 2014
- Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart DiseaseJACC, 2012
- Additive Beneficial Effects of Fenofibrate Combined With Atorvastatin in the Treatment of Combined HyperlipidemiaJACC, 2005
- Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)The American Journal of Cardiology, 2005